Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Crago AM, Cardona K, Koseła-Paterczyk H, Rutkowski P.
Surg Oncol Clin N Am. 2022 Jul;31(3):419-430. doi: 10.1016/j.soc.2022.03.006.
PMID:35715142
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S.
Lancet Oncol. 2017 Nov;18(11):1493-1501. doi: 10.1016/S1470-2045(17)30624-1. Epub 2017 Oct 4.
PMID:28988646
Cytology of Undifferentiated Round-Cell Sarcomas of Bone and Soft Tissue: Ewing Sarcoma or Not Ewing Sarcoma, That Is the Question.
Gajdzis P, Pierron G, Klijanienko J.
Acta Cytol. 2022;66(4):295-306. doi: 10.1159/000518146. Epub 2021 Aug 25.
PMID:34515032
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives.
Sbaraglia M, Bellan E, Dei Tos AP.
Pathologica. 2021 Apr;113(2):70-84. doi: 10.32074/1591-951X-213. Epub 2020 Nov 3.
PMID:33179614
Small round cell sarcomas.
Cidre-Aranaz F, Watson S, Amatruda JF, Nakamura T, Delattre O, de Alava E, Dirksen U, Grünewald TGP.
Nat Rev Dis Primers. 2022 Oct 6;8(1):66. doi: 10.1038/s41572-022-00393-3.
PMID:36202860
Clinical characteristics of undifferentiated pleomorphic sarcoma of bone and the impact of adjuvant chemotherapy on the affected patients: a population-based cohort study.
Kobayashi H, Zhang L, Hirai T, Tsuda Y, Ikegami M, Tanaka S.
Jpn J Clin Oncol. 2022 May 31;52(6):589-598. doi: 10.1093/jjco/hyac017.
PMID:35184191
Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
Ali NM, Niada S, Brini AT, Morris MR, Kurusamy S, Alholle A, Huen D, Antonescu CR, Tirode F, Sumathi V, Latif F.
J Pathol. 2019 Feb;247(2):166-176. doi: 10.1002/path.5176. Epub 2018 Dec 27.
PMID:30281149
Comparison of Features and Outcomes of Undifferentiated Pleomorphic Sarcoma of Bone and Soft Tissue.